文献速递腹部MR

非酒精性脂肪性肝病相关肝细胞癌:肝脏脂肪变对MRI上肝细胞癌主要特征的影响

Non-alcoholic fatty liver disease-associated hepatocellular carcinoma: effect of hepatic steatosis on major hepatocellular carcinoma features at MRI.
PubMed 文献 · Br J Radiol · 2018-08-29

研究纳入48例经组织学证实的非酒精性脂肪性肝病相关肝细胞癌患者,由三名放射科医师独立评估MRI上肝细胞癌及肝实质特征,并按肝脂肪信号分数分层分析。结果显示在非肝硬化形态患者中,肝脂肪信号分数每增加1%,门静脉期廓清缺失、延迟期廓清缺失和包膜表现缺失的比值比分别增加18%、14%和22%。作者结论认为廓清缺失和包膜表现缺失与肝脂肪变程度增加相关。

要点

  • 非肝硬化形态的NAFLD相关HCC中,肝脂肪信号分数每增加1%,门静脉期廓清缺失的比值比增加18%。
  • 肝脂肪信号分数≥14.8%时,非肝硬化形态患者中门静脉期廓清缺失的敏感度64%、特异度90%。
  • 肝脂肪信号分数≥14.8%时,非肝硬化形态患者中延迟期廓清缺失的敏感度71%、特异度90%。

核心结论

  • 在非肝硬化的非酒精性脂肪性肝病相关肝细胞癌患者中,肝细胞癌廓清缺失和包膜表现缺失与肝脂肪变程度增加相关,可能影响这些患者的无创影像诊断。

研究设计与样本

  • 回顾性分析48例连续的非酒精性脂肪性肝病患者中经组织学证实的肝细胞癌(平均±标准差4.5±3.4 cm),由三名放射科医师独立评估MRI上肝细胞癌及肝实质特征,肝脂肪信号分数独立计算,采用logistic回归和Cochran-Armitage趋势检验分析。

关键影像表现/征象

  • 动脉期高强化见于45例(93%),门静脉期廓清见于30例(63%),延迟期廓清见于38例(79%),强化「包膜」见于34例(71%)。
  • 肝硬化形态见于22例(46%)。
  • 评估者间一致性:动脉期高强化为0.75,门静脉期廓清为0.42-0.58,延迟期廓清为0.58-0.71,强化「包膜」为0.38-0.67。

诊断标准与关键数值

  • 在非肝硬化形态患者中,肝脂肪信号分数每增加1%,门静脉期廓清缺失的比值比增加18%(p=0.011)。
  • 在非肝硬化形态患者中,肝脂肪信号分数每增加1%,延迟期廓清缺失的比值比增加14%(p=0.040)。
  • 在非肝硬化形态患者中,肝脂肪信号分数每增加1%,包膜表现缺失的比值比增加22%(p=0.029)。
  • 在非肝硬化形态患者中,肝脂肪信号分数≥14.8%对门静脉期廓清缺失的敏感度64%、特异度90%。
  • 在非肝硬化形态患者中,肝脂肪信号分数≥14.8%对延迟期廓清缺失的敏感度71%、特异度90%。

临床应用与阅片要点

  • 在非肝硬化NAFLD相关HCC患者中,肝脂肪变程度增加时廓清和包膜表现可能缺失,阅片时需结合肝脂肪信号分数评估。
  • 作者认为,在脂肪肝中MRI上缺乏廓清或包膜表现时,可能需要替代标准来诊断非肝硬化NAFLD患者的HCC。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE:: To evaluate the effect of hepatic steatosis on LI-RADS® major features at MRI in patients with non-alcoholic fatty liver disease (NAFLD)-associated hepatocellular carcinoma (HCC).

METHODS:: HCC and liver parenchyma features at MRI from 48 consecutive patients with NAFLD and histology proven HCC (mean ± SD; 4.5 ± 3.4 cm) were independently reviewed by three radiologists. Inter-rater agreement was determined by prevalence/bias-adjusted kappa. Hepatic fat signal fraction (FS%) was independently calculated. HCC features were compared by FS% at MRI using logistic regression analysis and histologic steatosis grade using Cochran-Armitage test for trend, stratified by cirrhotic liver morphology or histologic fibrosis stage. Receiver operating characteristic curves were generated to determine the sensitivity and specificity for major HCC features by FS%.

RESULTS:: Major HCC features included arterial phase hyperenhancement (APHE) in 45 (93%), portal venous phase washout (PVWO) in 30 (63%), delayed phase washout (DPWO) in 38 (79%) and enhancing "capsule" in 34 (71%). Cirrhotic morphology was present in 22 (46%). Inter-rater agreement was 0.75 for APHE, 0.42-0.58 for PVWO, 0.58-0.71 for DPWO and 0.38-0.67 for enhancing "capsule". There was an 18%, 14% and 22% increase in the odds of absent PVWO, DPWO and capsule appearance for every 1% increase in hepatic FS% in patients with non-cirrhotic liver morphology (p = 0.011, 0.040 and 0.029, respectively). Hepatic FS% ≥ 14.8% had a sensitivity and specificity of 64 and 100% for absent PVWO and 71 and 90% for absent DPWO in patients with non-cirrhotic liver morphology.

CONCLUSION:: Absent washout and capsule appearance are associated with increasing hepatic steatosis in patients with non-cirrhotic, NAFLD-associated HCC.

ADVANCES IN KNOWLEDGE:: In patients with non-cirrhotic, non-alcoholic fatty liver disease (NAFLD)-associated hepatocellular carcinoma (HCC), absent HCC washout and capsule appearance are associated with increasing hepatic steatosis, thereby potentially impacting the noninvasive imaging diagnosis of HCC in these patients. Lack of washout or capsule appearance in steatotic livers at MRI may require alternative criteria for the diagnosis of HCC in patients with non-cirrhotic NAFLD.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Thompson SM, Garg I, Ehman EC, et al. Non-alcoholic fatty liver disease-associated hepatocellular carcinoma: effect of hepatic steatosis on major hepatocellular carcinoma features at MRI. Br J Radiol. 2018. PMID: 30074820. doi:10.1259/bjr.20180345

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。